In United States
Lupin announced that its US subsidiary, Lupin Pharmaceuticals Inc. has launched its Donepezil Hydrochloride Tablets, 23 mg having received approval from the United States Food & Drug Administration earlier to market a generic equivalent of Eisai Inc's Aricept Tablets, 23 mg. It is indicated for the treatment of dementia of the Alzheimers's type.Powered by Capital Market - Live News
